LONDON, Oct. 22, 2014 /PRNewswire/ -- This report covers the specifics of microRNA (miRNA) as it is a relatively new space in heavy pursuit of research due to its versatility and stability, properties that are unique to miRNAs compared to other RNA components. miRNA's non-coding nature and ability to affect genetic expression make it a novel candidate for use as a biomarker for a variety of diseases. This prompted the pursuit of miRNA-based microarrays and diagnostics for the advancement in therapeutic development. Furthermore there are a number of academic laboratories not only validating miRNAs, but also identifying them in a number of diseases and examining their molecular actions in the presence of other molecules. This report is broken up into several parts, highlighting miRNA in several areas of research.
After covering background information, the second and third parts of this report expand upon several microarrays and diagnostics for specific analysis and therapeutic development. Several companies featured in this section include: • Affymetrix • Exiqon • Diamir • Rosetta Genomics • Eisai • miRNA Therapeutics
Chapters within these sections feature company backgrounds and highlight proprietary technologies and platforms. Additionally, several advantages and limitations are also discussed. More significantly, these chapters are accompanied by interviews with company representatives, exclusively conducted for this report.
The fourth part of this report explores the academic, research and community perspectives. Although not developing diagnostics per se, academia is diligently investigating several aspects of miRNAs including their molecular properties for use as biomarkers for neurodegenerative diseases, diabetes, and even cancer. Universities and research institutes included in this area are: • Stony Brook University School of Medicine • Grand Valley State University • Van Andel Research Institute
Also included in these sections are interviews with experts in leading research from these universities. From a community perspective, Dr. Argyropoulos, a Medical Affairs Consultant, provides insight to the rapidly growing space and rising opportunities.
Finally, the report concludes with an in depth analysis of survey results. With 152 researchers, these results provide an overall perspective of the research community, capturing a number of miRNA applications, challenges afloat in the industry, and miRNA mechanisms of study.
Download the full report: https://www.reportbuyer.com/product/2116707/
About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers http://www.reportbuyer.com
For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: query@reportbuyer.com Tel: +44 208 816 85 48 Website: www.reportbuyer.com
HUNTINGTON, N.Y., Oct 28, 2014 /PRNewswire/ -- VisiVite, one of the world's leading eye vitamin manufacturers, has sold its millionth capsule. This landmark number reveals just how far the company's mission to promote vision health has extended, reflecting thousands of loyal customers who have benefited from VisiVite's sight-supportive vitamin, mineral and antioxidant formulas. "I'm thrilled to reach the milestone of one million capsules sold," says Dr. Paul Krawitz, the university eye surgeon who founded VisiVite in 2001. "What makes me truly proud, however, is the number of people who have maintained their healthy vision because they've chosen VisiVite supplements." He credits the company's success to a combination of three key factors. First and foremost, Krawitz acknowledges that VisiVite has always kept a keen focus, fittingly enough, on eye vitamins. He comments, "We were the first company to sell macular health supplements with vitamins and minerals combined with lutein and zeaxanthin, two science-backed carotenoids that are integral to vision wellness." Since optimal sight has consistently been VisiVite's objective, the company's trajectory has always been clear.Secondly, VisiVite enjoys a high level of customer allegiance, in part because it avoids trendy ingredients. Krawitz and his team are instead committed to using only researched-supported compounds in VisiVite supplements – choosing to sidestep untested components that may not confer benefits to their customer base. He explains, "VisiVite features proven formulas that have been meticulously calibrated through years of rigorous scientific study. Flashy, flavor-of-the-month ingredients are not a part of VisiVite's outlook."Thirdly, VisiVite's dedication to quality is unfailingly steady. The company uses only premium-quality raw materials, including FloraGLO® Lutein, a trusted brand of the marigold-sourced botanical nutrient, and OmniXan® Zeaxanthin, a prized natural compound derived from paprika. These and other highly bioavailable natural extracts are thoroughly analyzed and inspected before their inclusion in VisiVite supplements, which are delivered in easy-to-take and readily absorbed vegetarian capsules. Krawitz says, "Pure ingredients and exceptional quality standards form the foundation of our superior results."It's all a part of Dr. Krawitz's vision of healthy eyesight for everyone, and he remains intent on bringing these ideals into the future. "We're just getting started," Krawitz says. "With so many loyal customers, amazing word-of-mouth referrals and increasing awareness of how supplements can help preserve healthy vision for life, it's only a matter of time before we hit two million capsules sold... and beyond."VisiVite products are sold at VisiVite.Com, Vision-Nutrition.Com, BestEyeVitamins.Com, Amazon.Com and participating nutritional supplement stores and doctor offices. Wholesale accounts with a business tax ID number are welcomed.These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. This product is not intended to be a substitute or replacement for any drug, surgery or any other medical treatment. Seek the advice of a competent health care professional for your specific health concerns. Individual results may vary.Web: visivite.comPhoto - http://photos.prnewswire.com/prnh/20141027/154465
DUBLIN, Oct. 23, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Biometrics Market in Europe 2014-2018" report to their offering. Biometrics is a technology which helps to assess individuals on the basis of their physical or behavioral patterns. It involves the verification and identification of both physiological traits such as fingerprints, face recognition, DNA, palm print, hand geometry, and iris recognition, and behavioral traits such as keystroke patterns and speech pattern/voice recognition. The data derived are then used for security and authentication purposes, as it is difficult to forge biometric data. Biometrics is mainly used for law enforcement, banking authentication, and providing physical access. It helps provide an extra layer of security for data access and individual identification.
The analysts forecast the Biometrics market in Europe will grow at a CAGR of 17.25 percent during the period 2013-2018.
This report covers the present scenario and the growth prospects of the Biometrics market in Europe for the period 2013-2018. To calculate the market size, the report considers revenue generated from the sales of biometrics solutions. It also presents the vendor landscape and a corresponding detailed analysis of the top four vendors in the market.
In addition, the report discusses the major drivers that influence the growth of the Biometrics market in Europe. It also outlines the challenges faced by vendors and the market at large, as well as the key trends that are emerging in the market.
Currently, the adoption rate of fingerprint identification technology in ATMs in developing regions in Europe is low. One of the primary reasons for this is the lack of awareness about ATMs and the inability to operate them. Therefore, many banks have introduced ATMs integrated with biometrics in order to make it easier for end-users to access their accounts.
In addition, ATMs integrated with biometrics do not require a communication infrastructure. Moreover, the adoption of biometrics in the BFSI sector eliminates the need for ATM cards, saving huge costs for banks. This trend is gradually catching up, and the region is expected to witness an increase in the integration of biometrics in ATMs in the future.
According to the report, the growing need for advanced security in the Government sector is one of the drivers in this market. Government departments such as intelligence, defense, finance, and military are the major users of facial recognition technology. To secure their perimeter, government departments of various countries have installed stronger security measures, including biometric security solutions. In recent years, the Government sector has been the major contributor of revenue for the market.
Further, the report states that one of the key challenges in the market is the strong competition it faces from inexpensive non-biometric technologies. The presence of low-cost alternative technologies such as swipe cards, token-based two-factor authentication, and software authentication is a major challenge affecting the growth of the Biometrics market in Europe.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
05. Introduction
06. Market Description
07. Market Landscape
08. Market Segmentation by Technology
09. Market Segmentation by Application
10. Market Segmentation by End-users
11. Key Leading Countries
12. Biometrics Market in UK
13. Biometrics Market in Germany
14. Biometrics Market in France
15. Biometrics Market in Italy
16. Biometrics Market in Poland
17. Buying Criteria
18. Market Growth Drivers
19. Drivers and their Impact
20. Market Challenges
21. Impact of Drivers and Challenges
22. Market Trends
23. Trends and their Impact
24. Vendor Landscape
25. Key Vendor Analysis
26. Other Reports in this Series Companies Mentioned:
3M Cogent Inc. Cognitec Systems GmbH NEC Corp. Safran SA Animetrics Inc. Aware Inc. BIO-Key International Inc. Biometix Pty Ltd. Cross Match Technologies Inc. DigitalPersona Inc. Fujitsu Ltd. Lumidigm Inc. M2SYS LLC Siemens AG Suprema Inc. ZKTeco Inc. For more information visit http://www.researchandmarkets.com/research/wj3dzp/biometrics_market Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net
